NCT06811454Not yet recruiting
Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)
A Daily, Digital Mindfulness-Based Intervention for Depressive Symptoms After Serious Medical Illness
Source: ClinicalTrials.gov · Last updated 23 Jan 2026
Brief summary (registry, in English)
The purpose of this study is to develop and test a new intervention to reduce depressive symptoms in post-treatment cancer participants.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 76 (estimated)
- First submitted
- 31 Jan 2025
- Start date
- 3 Aug 2026
- Primary completion date
- 31 Mar 2028
- Lead sponsor
- Case Comprehensive Cancer Center
- NCT number
- NCT06811454
What you commit to
- Study type: Interventional
- Planned participants: 76
- From 3 Aug 2026 to the primary completion date, 31 Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior participation in a formal mindfulness program (e.g., MBCT, Mindfulness-Based Stress Reduction Program, Mindfulness-Based Cancer Recovery
Other illness
- Another psychological, medical, or other condition/issue determined that necessitates priority treatment and/or that would interfere with participation (e.g., schizophrenia, borderline personality disorder)
- Stage IV cancer diagnosis.
- A cancer recurrence actively requiring treatment.
Other
- Self-reported minimal and severe depressive symptoms (\<4 and \> 20 on PHQ-9).
- Self-reported suicidal ideation (\>1 on item 9 PHQ-9).
- Current or recent substance abuse/dependence.
- Self-reported active mindfulness practice.
Who the study is looking for
- Self-reported mild to moderately-severe symptoms of depression (score 5-19 on PHQ-9).
- A diagnosis of stage 0-III breast, prostate, or colorectal cancer.
- Completion of primary cancer treatment within 2 years (excludes hormone therapy).
- An ability to provide informed consent.
- An ability to read and speak English.
- Access to a web-enabled device (phone, tablet, computer).
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Case Comprehensive Cancer Center, Cleveland Clinic Foundation Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.